Citadel Advisors »

Jade Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Jade Biosciences (JBIO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Jade Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Jade Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jade Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $556k 36k 15.43

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs Call Option (GLD)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Advanced Micro Devices Call Option (AMD)

View all positions for Citadel Advisors

Top funds holding Jade Biosciences

FMR
Fairmount Funds Management
RA Capital Management
Bellevue Group
VR Adviser
BlackRock
Vanguard Group
Vanguard Capital Management
Baker Bros. Advisors
Versant Venture Management
Rtw Investments
Avidity Partners Management
Samsara BioCapital
Driehaus Capital Management
Marshall Wace

View all funds holding Jade Biosciences